Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Crestor Adverse Events Comparable to Zocor In Statin Safety Report

Jul 25 2005

• By The Pink Sheet

Related Content

To Crestor’s Foe, FDA Says Toxicity Is Low, But DTC Ads Must Go

Mar 21 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window